March 19, 2021 12:09
Korea will not suspend jabs of AstraZeneca's coronavirus vaccine despite mounting evidence of side effects including blood clots found in two recipients here, the Korea Disease Control and Prevention Agency said Thursday.
Health authorities said the second patient who developed blood clots here is a man in his 20s who works as a COVID-19-related health worker and got his jab on March 10. He complained of headache and chills soon afterwards and four days later of nausea.
He went to hospital on Monday when the side effects continued, and an MRI scan revealed blood clots and brain lesions. However, the link between his symptoms and the vaccine has yet to be established.
The first patient with blood clots was a woman in her 60s who died on March 6 after being vaccinated in late February.
Controversy continues, but the European Medicines Agency said the benefits of the AstraZeneca vaccine still outweigh the risks.
The rate of blood clots forming after AstraZeneca injections is still lower than ordinary rates for other reasons.
According to the EMA, around 5 million Europeans had been vaccinated with it as of March 11 but there have been only 30 reported cases of blood clots.
Blood clots were also found in people who were given the Pfizer vaccine. In the U.K., 9.7 million people got AstraZeneca shots and 10.7 million Pfizer injections, and there were 27 cases of blood clots among the former and 23 among the latter.
- Copyright © Chosunilbo & Chosun.com